Skip to main content

Table 2 IFAT score changes in G1 and G2 treated dogs during follow-up post-therapy. Data are reported as mean and (SD)

From: Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol

Time course

G1

G2

p*

months

n = 9

n = 9

Basal

2.8

3.3

0.1093

(1.1)

(0.7)

1

1.3

3.3

0.0001

(0.9)

(0.7)

3

2.6

2.3

0.2818

(0.5)

(1.0)

6

1.6

3.2

0.0004

(0.7)

(1.0)

9

0.9

1.2

0.1408

(0.3)

(0.8)

12

1.1

1.0

0.4050

(1.2)

(0.7)

15

1.0

1.2

0.2177

(0.5)

(0.7)

18

1.0

0.9

0.2934

(0.0)

(0.6)

21

0.9

1.0

0.3377

(0.6)

(0.5)

24

0.9

1.3

0.0537

(0.6)

(0.5)

28

1.0

1.6

0.1550

(0.7)

(1.4)

36

1.0

1.4

0.1277

(0.9)

(0.7)

48

1.0

1.6

0.0982

(0.5)

(1.1)

60

1.0

1.2

0.1661

(0.0)

(0.7)

72

0.3

0.8

0.0646

(0.5)

(0.7)

  1. *Student’s t-test probability significance between groups